O3‐06‐06: The Projected impact of risk factor reduction on Alzheimer's disease prevalence
By Marie-Noël Vercambre, Francine Grodstein, JoAnn Manson, MR Stampfer, J. H. Kang. 2011
2,379 citations recorded by the source corpus.
Subfields: Geriatrics and Gerontology, Psychiatry and Mental health, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/1cf0ffa6f56fc6a593a5cdb32353dd980fff6be4
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Psychiatry and Mental health
- J. Attems
- C. D’Arcy
- Christian Gaser
- Julie A. Schneider
- G. Kelley
- S. Brennan
- José Luis Molinuevo
- M. Prince
In Public Health, Environmental and Occupational Health
Citations in the corpus
- Association of Age-Related Hearing Loss With Cognitive Function, Cognitive Impairment, and Dementia (2017, background): “DATA SOURCES AND STUDY SELECTION A search of PubMed, the Cochrane Library, EMBASE, and SCOPUS from inception to April 15, 2016, with cross-referencing of retrieved studies and personal files for potentially eligible studies was performed.”
- Alzheimer’s disease prevention: from risk factors to early intervention (2017, background): “60), nearly 14% of AD cases are estimated to be potentially attributable to smoking due to its high prevalence [9].”
- Recent global trends in the prevalence and incidence of dementia, and survival with dementia (2016, background): “prevention of dementia by targeting modifiable risk factors [24, 25], the quality and extent of the evidence has ex-”
- Inequalities in dementia incidence between six racial and ethnic groups over 14 years (2016, background): “In the case of dementia, the most compelling explanations relate to established risk factors for dementia, such as education and vascular comorbidities [8,39].”
- The global prevalence of dementia: A systematic review and metaanalysis (2013, neutral): “1 million cases worldwide [61].”
- Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies (2013, neutral): “Given the present results in this meta-analysis, the estimated number of cases of dementia attributable to depression, including lifetime and late-life depression, is probably higher than those reported by Barnes & Yaffe, 6 and the prevention of lifetime and late-life depression would possibly have ”
- Understanding the impact of sex and gender in Alzheimer's disease: A call to action (2018, positive): “Cardiometabolic risk factors Several studies have identified modifiable cardiometabolic diseases including type 2 diabetes, metabolic syndrome, obesity, and other cardiovascular risk factors for the development and progression of AD [17].”
- Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis (2014, result): “It is also among few recent studies to compare the strength of association across those factors in relation to incident AD using a similar approach [19,20].”
- Impact of multiple pathologies on the threshold for clinically overt dementia (2017, background): “This evidence makes it likely that the cooccurrence of CVD increases dementia risk in later life as suggested by risk factor analyses based on epidemiological studies [68], and points to potential therapeutic interventions that may substantially reduce dementia incidence through the aggressive contr”
- A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer’s disease (2018, background): “More than 30 million people have a clinical diagnosis of Alzheimer's disease (AD) worldwide, and this number is expected to triple by 2050 (Barnes and Yaffe, 2011).”